cetylpyridinium chloride anhydrous has been researched along with Hepatitis E in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Hirose, A; Masuko, K; Mitsui, T; Okamoto, H; Suzuki, S; Takahashi, M; Tsuda, F; Tsukamoto, Y; Yamazaki, C | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Hepatitis E
| Article | Year |
|---|---|
Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan.
Topics: Acute Disease; Adolescent; Adult; Aged; Aging; Child; Female; Health; Health Personnel; Hepatitis A; Hepatitis A virus; Hepatitis Antibodies; Hepatitis E; Humans; Immunoglobulin G; Japan; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Prevalence; Renal Dialysis | 2006 |